During the pre-implementation phase, vGenix Ai will gather all required customer data and information necessary for optimal configuration of the Pharmacovigilance Automation. The primary objectives of this phase are:

• To collect detailed requirements for engine customization, including client-specific guidelines and Standard Operating Procedures (SOPs), enabling the engine to accurately replicate existing processes.
• To compile a comprehensive dataset of historical documents and associated metadata for training and testing purposes.
• This data will be utilized to tailor the engine to the client's specific needs and validate the accuracy of engine customization throughout the implementation process, ensuring alignment with the client's quality standards.

The Discovery Phase marks the initial stage of implementation with vGenix Ai. During this phase, our team will thoroughly review the data collected during the pre-implementation phase and conduct a series of collaborative activities and discussions to gain a comprehensive understanding of your data and engine customization requirements. A manual document processing audit will be performed, incorporating your feedback, to validate our understanding and ensure accuracy prior to engine configuration.

In parallel, we will work closely with your technical team to design a tailored production workflow. This will involve sharing best practices from similar implementations and customizing the integration to align with your existing systems and operational requirements. The workflow design will be optimized to meet our committed Turnaround Time (TAT) standards, ensuring efficient and effective Pharmacovigilance Automation.

The second phase of implementation with vGenix Ai involves the configuration and integration of our Pharmacovigilance Platform. Based on the requirements defined during the Discovery Phase, our team will configure the engine to accurately process your data. We will utilize the historical data provided to thoroughly test the configuration, ensuring it meets the intended outcomes.

Concurrently, our technical teams will develop the technical integration as designed during the Discovery Phase, aligning with your specific requirements and systems. This integrated approach ensures a seamless and effective implementation of the Pharmacovigilance Automation.

The third phase of implementation with vGenix Ai centers on User Acceptance Testing (UAT). During this phase, you will begin sending daily batches to vGenix Ai for processing by our Pharmacovigilance AI Engine. To ensure quality and accuracy, a random subset of processed documents will undergo rigorous auditing by our quality team to identify and rectify any critical errors or compliance issues.

Concurrently, the technical integration will be thoroughly tested to validate its functionality and performance. Upon successful completion of UAT, and meeting predefined go-live criteria - including achieving 95% or higher accuracy and adhering to the expected turnaround time - we will collaboratively determine a go-live date, marking the transition to full production.

Upon completion of Phase 3 and the commencement of service, vGenix Ai's Pharmacovigilance AI Engine will be fully operational, automating Pharmacovigilance workflows for the customer. To ensure ongoing quality, vGenix Ai and the customer will regularly assess the accuracy of processed documents, targeting a sustained accuracy rate of 95% or higher.

In production, we anticipate that 70% of documents will be automatically processed without human intervention, although this coverage may vary depending on the specific domain or problem statement. This automation enables significant efficiency gains while maintaining high accuracy standards.